Find Reports
Select Report Type
Reimbursement Review
Displaying 1101 - 1125 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| tirzepatide | TBC | tirzepatide | Diabetes mellitus, type 2 | Cancelled | SR0751-000 | ||||
| ferumoxytol | TBC | ferumoxytol | Iron deficiency anemia | Withdrawn | SR0753-000 | ||||
| Triple Negative Breast Cancer | Triple Negative Breast Cancer | Complete | PH0024-000 | ||||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| clascoterone | Winlevi | clascoterone | Acne vulgaris | Withdrawn | SR0786-000 | ||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| daprodustat | TBC | daprodustat | Anemia due to chronic kidney disease | Withdrawn | SR0762-000 | ||||
| brentuximab vedotin | Adcetris | brentuximab vedotin | Hodgkin lymphoma | Withdrawn | PC0311-000 | ||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| HER2 Positive Metastatic Breas... | HER2 Positive Metastatic Breast Cancer | Complete | PH0016-000 | ||||||
| Hormone receptor (HR) positive... | Hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer | Complete | PH0018-000 | ||||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| cyclosporine | Ikervis | cyclosporine | keratitis, severe | Withdrawn | SR0518-000 | ||||
| fluticasone furoate/vilanterol | Breo Ellipta | fluticasone furoate/vilanterol | COPD | Withdrawn | SR0524-000 | ||||
| RFA: Inlyta for Metastatic Ren... | Inlyta (RFA) | Axitinib | Metastatic Renal Cell Carcinoma | N/A | Complete | PA0001-000 | |||
| Mvasi for Metastatic Colorecta... | Mvasi | Bevacizumab | mCRC NSCLC Biosimilar | N/A | Complete | PC0158-000 | |||
| fluticasone furoate/vilanterol | Breo Ellipta | fluticasone furoate/vilanterol | Asthma | Withdrawn | SR0568-000 | ||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| tofacitinib | Xeljanz | tofacitinib | Cancelled | SR0575-000 | |||||
| Beleodaq for Peripheral T-Cell... | Beleodaq | Belinostat | Withdrawn | PC0139-000 | |||||
| Blincyto for MRD-positive B-ce... | Blincyto | Blinatumomab | Withdrawn | PC0143-000 | |||||
| Rituximab for Non-Hodgkin’s Ly... | TBD | Rituximab | Cancelled | PC0180-000 | |||||
| CADTH Pharmaceutical Reviews U... |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1101 - 1125 of 2132
Please scroll or swipe to the right to view the full content.